Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Kathryn LurainTalal El ZarifRamya RamaswamiAmin H NassarElio AdibNoha Abdel-WahabNikita ChintapallyClaire E DrolenTatyana FeldmanTarek HaykalCaroline A NebhanSwetha KambhampatiMingjia LiArjun MittraMichael LorentsenChul KimAlexandra DrakakiMichael MorseDouglas B JohnsonAnkit ManglaChristopher DittusPraful RaviRobert A BaiocchiElizabeth Y ChiaoPaul G RubinsteinSarvari V YellapragadaAnn S LaCasceGuru P SonpavdeAbdul Rafeh NaqashAlex F HerreraPublished in: Clinical lymphoma, myeloma & leukemia (2024)
Our findings support the use of PD-1 blockade in HIV-cHL for the same indications as the general population with cHL.